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ABSTRACT 
The ecotoxicity testing of chemicals for prospective environmental safety assessment is an 
area where a high number of vertebrates are used across a variety of industry sectors. 
Refining, reducing and replacing the use of animals such as fish, birds and amphibians for 
this purpose addresses the ethical concerns and the increasing legislative requirements to 
consider alternative test methods. Members of the UK-based National Centre for the 
Replacement, Refinement and Reduction of Animals in Research (NC3Rs) Ecotoxicology 
Working Group, consisting of representatives from academia, government organisations and 
industry, have worked together over the past six years to provide evidence bases to support 
and advance the application of the 3Rs in regulatory ecotoxicity testing. The group recently 
held a workshop to identify the areas of testing, demands and drivers that will impact on the 
future of animal use in regulatory ecotoxicology. As a result of these discussions we have 
developed a pragmatic approach to prioritise and realistically address key opportunity areas, 
to enable progress towards the vision of a reduced reliance on the use of animals in this area 
of testing. This paper summarises the findings of this exercise and proposes a pragmatic 
strategy towards our key long-term goals – the incorporation of reliable alternatives to whole 
organism testing into regulations and guidance, and a culture shift towards the reduced 
reliance on vertebrate toxicity testing in routine environmental safety assessment.  
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INTRODUCTION 
Many organisations across various sectors have an aspirational goal that scientific and 
technological advances may eventually enable the replacement of animal toxicity testing in 
the evaluation of product safety. Approaches which support the 3Rs principles (Reduction, 
Refinement and Reduction of animal testing; Box 1) are already practiced in some sectors; in 
particular, replacements are being sought to traditional animal tests through the use of cell-
based (in vitro) and computational (in silico) methods within the cosmetics and personal care 
products industry, due to restriction or exclusion of the testing of such products in animals. 
However, until such approaches are more widely developed, validated and accepted, 
regulatory safety standards and industries’ duty of care to humans and the environment 
means that today some animal tests remain integral to the assessment of the health, safety and 
potential environmental impact of chemical, agrochemical and pharmaceutical products, 
intermediates and raw materials. There are opportunities however to challenge existing 
practices and determine how they can be improved, while at the same time exploring and 
developing the use of alternatives to in vivo testing. 
Ecotoxicity testing is widely undertaken to prospectively assess the impact of 
chemicals on wildlife populations and ecosystems and is one area which represents a 
significant source of vertebrate animal use across a number of industry sectors. Fish, 
followed by birds and amphibians, are the most commonly used vertebrate species in such 
regulatory environmental safety assessments. According to the most recent statistics from the 
European Union (EU),  almost 200,000 animals from these groups were used in 2011 for 
toxicological or other safety evaluations, with over half of those tests carried out to meet 
regulatory requirements (EC 2013). However this area has historically received much less 
attention in terms of the 3Rs principles than the mammalian toxicity testing undertaken to 
assess human safety.   
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Advancing the 3Rs in ecotoxicology will not only address ethical concerns but also 
the legislative demands to find alternative non-animal methods, and share data wherever 
possible. In Europe, for example, this is relevant to Article 62 of the Plant Protection 
Products Regulation (PPPR; EC 2009), Article 25 of the Registration, Evaluation, 
Authorisation & restriction of CHemicals (REACH) Regulation (EC 2006), and Article 62 of 
the Biocidal Products Regulation (BPR; EU 2012). Furthermore, it is no longer an option for 
the cosmetics industry to utilise animal tests in safety evaluations of their products in many 
parts of the world, for example in Europe (EC 2009), India (Indian Ministry of Health and 
Family Welfare 2014) and possibly with Australia and the US following suit 
(www.alp.org.au/cosmeticstesting; www.congress.gov/bill/113th-congress/house-bill/4148). 
The benefits of applying 3Rs approaches in ecotoxicology are potentially far reaching, 
particularly considering the large numbers of substances requiring approval to sell worldwide 
(Muir and Howard 2006).  
The National Centre for the Replacement, Refinement and Reduction of Animals in 
Research (NC3Rs) is a UK-based independent scientific organisation set up by Government 
in 2004, to lead the discovery and application of new technologies and approaches which 
minimise the use of animals in research and improve animal welfare. The organisation’s in-
house programmes aim to provide scientific evidence bases which support the application of 
the 3Rs in a range of research areas. This is achieved through the creation of a proactive, 
collaborative environment which engages key stakeholders such as authorities, regulators, 
academics and industry practitioners, and is strengthened by the forging of international links 
to stimulate change at the global level. In 2008 the NC3Rs began a dedicated programme of 
work in the area of ecotoxicology, supported by a working group of experts in the field across 
academia, government agencies (including regulators), contract research organisations and 
industry (principally agrochemicals, personal care products and petrochemicals). The projects 
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initiated within the NC3Rs Ecotoxicology Working Group over the past six years have 
largely focussed on reducing the use of fish in the safety assessment of industrial chemicals 
and agrochemicals (Burden et al. 2014; Creton et al. 2014; Creton et al. 2010; Creton et al. 
2013), and build on the earlier 3Rs-related work of some members of the group (Douglas et 
al. 1986; Hutchinson et al. 2003; Jeram et al. 2005).  
This paper summarises discussions held at a recent workshop of the NC3Rs 
Ecotoxicology Working Group, which considered the future of animal use in the ecotoxicity 
testing required for product or substance registration. The group has used this sharing of 
knowledge and experience to develop a pragmatic approach to enable progress towards the 
vision of a reduced reliance on the use of animals in this area.  
 
TRENDS IMPACTING CURRENT AND FUTURE ANIMAL USE IN 
ECOTOXICOLOGY 
There have been considerable advances made in recent years in the science and 
methodology of alternative test methods in ecotoxicology, particularly in the area of acute 
fish toxicity (for example, the development of the zebrafish embryo test - Organisation for 
Economic Co-operation and Development (OECD) Test Guideline (TG) 236 (OECD 2013)), 
and there is evidence emerging from regulatory authorities that companies are increasingly 
making use of alternative approaches for regulatory purposes (e.g., see ECHA 2014). Efforts 
have also been made to refine and reduce the animal numbers used in in vivo tests, as 
demonstrated by the development of OECD TG 223 (avian acute oral toxicity test, OECD 
2010a) and the provision of guidance for the threshold approach for acute fish toxicity 
(OECD Guidance Document (GD) 126; OECD 2010b). There is nevertheless potential for 
further headway to be made towards both the refinement of animal tests and the application 
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of non-animal alternatives, for aquatic and terrestrial ecotoxicity testing. The detailed 
assessment carried out by the Working Group identified the areas of testing where high 
numbers of vertebrates are currently being used or a significant increase is anticipated, as 
well as the opportunities which exist to decrease or refine animal use. This review was used 
to pinpoint key focus areas for the group’s future activities, and is summarised in 
Supplementary Table 1. Four key areas of potential current and future high vertebrate usage 
were determined as: 1) the identification of endocrine disruptors; 2) the assessment of 
bioaccumulation; 3) acute and 4) chronic toxicity. Within some of these areas there is 
potential for a high degree of suffering to be experienced by the test animals (higher 
“severity” tests).  
Some universal drivers, which may contribute to changes in animal use across all 
these areas of testing, were highlighted by the group. One of these is the growth in 
complexity and breadth of risk assessments to address the needs of the legislation and the 
concurrent increase in uncertainty regarding some of the exposure estimates used. Many of 
these estimates are based on theoretical assumptions, rather than real exposure measurements, 
and often aim to cover a wide range of possible exposure scenarios. Typically ‘worst case’ 
exposure assessments are used, although refinement is possible to provide more ‘realistic’ 
values. However, refinements can be difficult especially  for diffuse exposure scenarios,,  
Therefore, refinement may be pursued by undertaking  additional toxicity studies as a means 
to reduce uncertainty in the effects assessment endpoint, and hence the overall risk 
assessment.  For example, as outlined in European Chemicals Agency (ECHA) Guidance 
Documents (e.g. ECHA 2011) the sparser the available data, the higher the 
assessment/uncertainty factor. Hence, having more acute and chronic toxicity data for 
different trophic levels (including fish) can reduce the assessment/uncertainty factor used to 
determine the predicted no effect concentration (PNEC), thus reducing the “apparent” risk 
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posed by chemicals. More realistic exposure modelling may go some way to alleviate the 
issue, so that the use of data from vertebrate test subjects to refine effects assessments is 
required less often. Further, more spatially or temporally explicit techniques could be 
employed to better represent the chemical contribution to overall risk (Hope 2004).  The 
increased breadth of the legislation has contributed to an increase in the scope of animal 
testing; under the PPPR for example, chronic fish testing is now a core requirement, as well 
as the inclusion of an assessment of endocrine disruption. The combination of these factors 
potentially leads to an increase in vertebrate testing. It is worth noting however that where 
informed exposure-led assessments are carried out, this can help to better design testing 
strategies and thus could contribute to a decrease in numbers of animals used; consideration 
of internal exposure concentration can also help to avoid the dosing of excessively high 
concentrations in later studies thus reducing the likelihood of inducing unnecessary animal 
suffering (Creton et al. 2012). 
Secondly, there is evidence that animal studies can be duplicated in closely related 
species from the same taxon (e.g. freshwater cyprinid fish (Oris et al. 2012)) to address 
different regulatory needs across the globe, and it is possible that higher severity/more animal 
intensive methods are being used to meet different national requirements to ensure the global 
registrations. Despite the obvious ethical concerns this raises, registrants generally 
incorporate the most extensive testing necessary to ensure global acceptability and associated 
freedom to market and sell their products. This is largely due to a lack of comprehensive 
harmonisation of global regulations, which occurs due to regional preferences and 
disagreement on standard test species or approaches. Furthermore, although test data 
generated in any OECD member country in accordance with OECD Test Guidelines and 
Principles of Good Laboratory Practice (GLP) can be accepted in other member countries for 
assessment purposes, requirements can exist for toxicity tests to be carried out locally, 
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particularly in the non-OECD member countries, despite data already being available from 
GLP OECD studies carried out elsewhere. The Globally Harmonized System of 
Classification and Labelling of Chemicals (GHS) is a rare example where fish toxicity tests 
carried out in any species under the relevant OECD Test Guideline are globally accepted.  
Finally, legislative demands in certain chemical sectors in some regions are 
contributing significantly towards increases in in vivo ecotoxicity testing, despite stipulations 
within various frameworks that animal testing should only be carried out as a last resort. This 
is in part a result of the reluctance of some national regulators to accept modelled information 
(derived from in silico or in vitro data), category and read across approaches, and a lack of 
recognition that regulatory endpoints may not automatically require a vertebrate test to fulfil 
them.  Data packages containing non-animal data which are acceptable within the EU are not 
always globally accepted, and therefore additional animal testing may be undertaken to meet 
the demands of other regulatory authorities. It is worth noting that there are scientific barriers 
that still need to be overcome before non-animal methods can be more widely utilised. In the 
case of computational models for instance, there is not always sufficient toxicity data 
available on certain molecular structures to be able to make confident predictions. 
Furthermore, information on toxicokinetics and thus relevant internal concentrations can be 
difficult to capture using cell-based assays. There is also recognition that alternative methods 
cannot realistically replace the whole animal tests on a like-for-like basis. This may be 
addressed in the long term by the development of better extrapolation models and integrated 
approaches to testing and assessment. Consideration of integrated approaches also highlights 
the importance of, and need for, the scientific aims of the risk assessment a priori – this will 
also help to avoid “box-ticking” exercises and ensure that vertebrate tests are only carried out 
when they add genuine value. 
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A PRAGMATIC APPROACH TOWARDS ADVANCING THE 3Rs  
This assessment of the current and future landscape was intended to not only highlight 
the potential to apply the 3Rs in ecotoxicology, but to help build a strategy whereby 
organisations such as the NC3Rs can apply their experience to address some of the issues, 
and reach key long-term goals. This must undoubtedly be approached in a practical and 
realistic way, through concurrent investment in both short- and medium-term endeavours, 
towards the key long term aims, as detailed in Figure 1. Adopting a complementary approach 
ensures that immediate impacts regarding a reduction in animal use can be achieved, whilst 
working towards those more time and resource-intensive aims. The undertaking of short-term 
projects will help to facilitate the medium-term approaches, and will also have value in 
addressing some of the drivers impacting on animal usage over the next three to five years 
(such as the EU REACH 2018 registration deadline, and the identification of Substance of 
Very High Concern (SVHCs) by 2020).  
When determining individual focus areas in which to invest and ensure maximum impact, 
the prioritisation of efforts and resource can be achieved through a cost/benefit analysis 
which considers a number of factors, including: 
 3Rs benefit – how many of the Rs will be addressed? What will the impact be in 
terms of decreasing the severity of tests/numbers of animals used? 
 Expected outcomes and impacts – how likely are the recommendations to be taken up 
across the scientific and regulatory communities and will they apply across sectors 
nationally and/or globally? 
  New areas compared with previous work/programmes of work undertaken within 
other scientific organisations, to ensure minimal duplication and add maximum value. 
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 Potential for collaboration across sectors, and with other scientific organisations 
where common interests and goals have been identified.  
 
Based on these factors, the Working Group assessed the potential 3Rs impact associated 
with investing resource into the opportunities to reduce, refine or replace animal use (as 
detailed in Supplementary Table 1) for each of the key focus areas of ecotoxicity testing, and 
prioritised them in the following order: 
1) Assessment of acute toxicity (fish and bird) – scope for a large reduction in both 
animal usage and testing severity.  
2) Assessment of bioaccumulation (fish) – scope for a large reduction in animal numbers 
used; although physico-chemical properties are already extensively used to predict 
bioaccumulation, in vivo  testing  is still often triggered as the metabolisn processes 
can often be a driving factor that is not well predicted in silico.  
3) Identification of endocrine disruptors (fish, amphibians and birds) – scope to further 
explore the necessity for high animal usage in reproductive/developmental screening 
assays carried out to meet regulatory protection goals (though note that test severity 
tends to be relatively low in the relevant in vivo tests). 
4) Assessment of chronic toxicity (fish) – scope to reduce animal usage, particularly 
where similar tests are conducted on multiple species (e.g. for global registrations). 
 
Furthermore, there are two key overarching themes where progress is essential to advance 
the global recognition and applicability of the 3Rs, with potential to impact on all four of 
the identified focus areas, and beyond: i) improvements in study design across all areas of 
ecotoxicity testing in order to provide adequate statistical power within studies, which 
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could lead to either the use of fewer animals and/or the generation of better quality data 
from in vivo tests (which can be achieved in the short-term); and ii) the harmonisation of 
global data packages (a longer-term aim). In order to achieve global harmonisation, 
dedicated assessments will need to be carried out in the first instance, to determine 
appropriate recommendations based on the areas where there is scope to align testing and 
data requirements.  This will need to be followed by co-ordinated large-scale international 
efforts and collaboration, to ensure that the recommendations are heeded. It is also of note 
that the recent interest and increasing investment into the development of adverse 
outcome pathways (AOPs; pathways which link a molecular initiating event for a 
chemical to an apical endpoint and subsequent organism/population effects, through a 
scientifically proven causal chain of events). Application of this concept in the long term 
has potential to transform the practice of (eco)toxicity testing, and provide tangible 3Rs 
benefits, for example by increasing confidence in cross-species extrapolations and read-
across approaches, as well as perpetuating the development of newnon-animal methods 
for use in safety assessment (Burden et al. 2015). This concept is being underpinned by a 
global initiative currently underway at the OECD, which provides an explicit, consensus-
led framework under which AOPs are developed and brings together the relevant 
communities; thus, establishment of robust AOPs for ecotoxicology endpoints is also 
considered a key long-term goal (Figure 1). The AOP framework provides a valuable 
opportunity for ecotoxicologists to share data on a large scale; initiatives such as this 
which facilitate data sharing, between both the regulatory and scientific communities, 
have potential to not only improve the science of ecotoxicology, but to accelerate the 
development and validation of non-traditional methods and approaches.  
Activities such as those related to improvements in study design and reporting will 
apply broader concepts to the field of ecotoxicology that are also relevant to academic 
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research. Many areas of basic research have started to apply the ARRIVE (Animal 
Research: Reporting of in Vivo Experiments) guidelines. These guidelines are a 20-point 
checklist of the essential information that should be included in publications reporting 
animal research, to improve standards of reporting and ensure that the data from animal 
experiments can be fully evaluated and utilised (Kilkenny et al. 2010). In this way 
consistency in the reporting of, for example, exposure routes and exposure concentrations 
can be ensured to enable comparisons between test methods on a like-for like basis. This 
is a key factor considering that alternative test methods are often ‘validated’ against 
existing in vivo data. If such an approach were globally endorsed, replication of 
experiments could be avoided and higher confidence attributed to methodology and 
results, thus increasing the robustness of open literature data. This is particularly 
significant because such data must now be included in dossiers submitted under various 
chemicals regulations. Better reporting and study design of basic research could therefore 
help to avoid the triggering of new animal tests, as reliable open literature data will be 
available more frequently. It is also paramount that detailed ecotoxicity data submitted to 
regulatory agencies is made available wherever possible, and is easily accessible.  
Promotion and uptake of standard reporting guidelines within ecotoxicology is a good 
example of how a short-term approach has scope to feed into longer-term 3Rs benefit.  
 
LOOKING TO THE FUTURE 
The next steps involve continuing to apply and progress the proposed strategy, 
through the continuation of efforts to work internationally, with the aim of addressing the key 
areas of concern. Mapping of priority areas to the existing opportunities to decrease or refine 
animal use, and the development of projects to facilitate novel advances within these areas, is 
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now underway. The commitment of industry to working alongside organisations such as the 
NC3Rs, who can take on the role of a neutral scientific forum to enable data sharing activities 
and involve regulators at the early stages of projects, stands the community in good stead to 
progress the 3Rs and improve animal welfare in this ever-evolving field. Through the 
continuation of committed collaboration and international coordination, the achievement of 
these aims will be increasingly realised. 
 
DISCLAIMER 
The views and statements expressed in this paper are those of the authors alone. The views or 
statements expressed in this publication do not necessarily represent the views of the 
organisations to which the authors are affiliated, and those organisations cannot accept any 
responsibility for such views or statements. 
  
 15 
 
REFERENCES 
Burden, N., Creton, S., Weltje, L., Maynard, S.K. and Wheeler, J.R. 2014. Reducing the 
number of fish in bioconcentration studies with general chemicals by reducing the number of 
test concentrations. Regulatory toxicology and pharmacology : RTP 70, 442-445. 
 
Burden, N., Sewell, F., Andersen, ME., Boobis, A., Chipman, J.K., Cronin, M.T., 
Hutchinson, T.H., Kimber, I., Whelan, M. 2015. Adverse Outcome Pathways can drive non-
animal approaches for safety assessment. Journal of applied toxicology, Epub ahead of print. 
 
Creton, S., Clook, M. and Wheeler, J.R. 2014. Application of the threshold approach for 
acute fish toxicity testing to plant protection products: a proposed framework. Chemosphere 
96, 195-200. 
 
Creton, S., Douglas, M., Wheeler, J.R. and Hutchinson, T.H. 2010. Challenging the 
requirement for chronic fish toxicity studies on formulated plant protection products. 
Toxicology letters 199, 111-114. 
 
Creton, S., Saghir, S.A., Bartels, M.J., Billington, R., Bus, J.S., Davies, W., Dent, M.P., 
Hawksworth, G.M., Parry, S. and Travis, K.Z. 2012. Use of toxicokinetics to support 
chemical evaluation: Informing high dose selection and study interpretation. Regulatory 
toxicology and pharmacology : RTP 62, 241-247. 
 
Creton, S., Weltje, L., Hobson, H. and Wheeler, J.R. 2013. Reducing the number of fish in 
bioconcentration studies for plant protection products by reducing the number of test 
concentrations. Chemosphere 90, 1300-1304. 
 
Douglas, M.T., Chanter, D.O., Bell, I.P. and Burney, G.M. 1986. A proposal for the reduction 
of animal numbers required for the acute toxicity to fish test (LC50 determination). Aquatic 
Toxicology 8, 243-249. 
[EC] European Commission. 2000. Directive 2000/60/EC of the European Parliament and of 
the Council of 23 October 2000 establishing a framework for Community action in the field 
of water policy. 
 
 16 
 
[EC] European Commission. 2006. Regulation (EC) No. 1907/2006 of the European 
Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction 
of Chemicals (‘REACH’). 
 
[EC] European Commission. 2009. Regulation (EC) No 1223/2009 of the European 
Parliament and of the Council of 30 November 2009 on Cosmetic Products. 
 [EC] European Commission. 2013. Seventh Report from the Commission to the Council and 
the European Parliament on the Statistics on the number of animals used for experimental and 
other scientific purposes in the member states of the European Union. Brussels: 
COM(2013)859/final. 
 
 [EC] European Commission. 2014. Defining criteria for identifying Endocrine Disruptors in 
the context of the implementation of the Plant Protection Product Regulation and Biocidal 
Products Regulation. http://ec.europa.eu/smart 
regulation/impact/planned_ia/docs/2014_env_009_endocrine_disruptors_en.pdf. Last 
accessed 18 November 2014.  
 
[ECHA] European Chemicals Agency. 2013. Guidance on information requirements and 
chemical safety assessment Part B: Hazard assessment. Helsinki, Finland: European 
Chemicals Agency. ECHA-11-G-16-EN. 
[ECHA] European Chemicals Agency. 2013. SVHC Roadmap to 2020 Implementation Plan. 
Helsinki, Finland: European Chemicals Agency. ECHA-13-R-11-EN. 
 
 [ECHA] European Chemicals Agency. 2014. The Use of Alternatives to Testing on Animals 
for the REACH Regulation (Second report under Article 117(3) of the REACH Regulation). 
Helsinki, Finland: European Chemicals Agency. ECHA-14-A-07-EN. 
 
[EFSA] European Food Safety Authority .2013; Guidance on tiered risk assessment for plant 
protection products for aquatic organisms in edge-of-field surface waters. EFSA Journal 
11(7):3290. 
 
 [EU] European Commission. 2009. Regulation (EC) No. 1107/2009 of the European 
Parliament and of the Council of 21 October 2009 concerning the placing of plant protection 
products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC.  
 17 
 
 
[EU] European Union. 2012. Regulation (EU) No. 528/2012 of the European Parliament and 
of the Council of 22 May 2012 concerning the making available on the market and use of 
biocidal products. 
 
[EU] European Union. 2013. Commission Regulation (EU) No 283/2013 of 1 March 2013 
setting out the data requirements for active substances, in accordance with Regulation (EC) 
No 1107/2009 of the European Parliament and of the Council concerning the placing of plant 
protection products on the market. 
 
Hope, B.K. 2005. Performing Spatially and Temporally Explicit Ecological Exposure 
Assessments Involving Multiple Stressors. Human and Ecological Risk Assessment: An 
International Journal. 11(3): 539-565. 
 
Hughes, M.M., Heber, M.A., Morrison, G.E., Schimmel, S.C. and Berry, W.J. 1989. An 
evaluation of a short-term chronic effluent toxicity test using sheepshead minnow 
(Cyprinodon variegatus) larvae. Environ Pollut 60, 1-14. 
 
Hutchinson, T.H., Barrett, S., Buzby, M., Constable, D., Hartmann, A., Hayes, E., Huggett, 
D., Laenge, R., Lillicrap, A.D., Straub, J.O. and Thompson, R.S. 2003. A strategy to reduce 
the numbers of fish used in acute ecotoxicity testing of pharmaceuticals. Environmental 
toxicology and chemistry / SETAC 22, 3031-3036. 
 
Hutchinson, T.H., Bogi, C., Winter, M.J. and Owens, J.W. 2009. Benefits of the maximum 
tolerated dose (MTD) and maximum tolerated concentration (MTC) concept in aquatic 
toxicology. Aquat Toxicol 91, 197-202. 
 
Indian Ministry of Health and Family Welfare. 2014. Drugs and Cosmetics (Fifth 
Amendment) Rules, 23 October 2014. The Gazette of India. 
 
Jeram, S., Sintes, J.M., Halder, M., Fentanes, J.B., Sokull-Kluttgen, B. and Hutchinson, T.H. 
2005. A strategy to reduce the use of fish in acute ecotoxicity testing of new chemical 
substances notified in the European Union. Regulatory toxicology and pharmacology : RTP 
42, 218-224. 
 18 
 
 
Kilkenny, C., Browne, W.J., Cuthill, I.C., Emerson, M. and Altman, D.G. 2010. Improving 
bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS 
biology 8, e1000412. 
Maynard, S.K., Edwards, P. and Wheeler, J.R. 2014. Saving two birds with one stone: using 
active substance avian acute toxicity data to predict formulated plant protection product 
toxicity. Environmental toxicology and chemistry / SETAC 33, 1578-1583. 
 
Muir, D.C. and Howard, P.H. 2006. Are there other persistent organic pollutants? A 
challenge for environmental chemists. Environmental science & technology 40, 7157-7166. 
 
Murk, A.J., Rijntjes, E., Blaauboer, B.J., Clewell, R., Crofton, K.M., Dingemans, M.M., 
Furlow, J.D., Kavlock, R., Kohrle, J., Opitz, R., Traas, T., Visser, T.J., Xia, M. and Gutleb, 
A.C. 2013. Mechanism-based testing strategy using in vitro approaches for identification of 
thyroid hormone disrupting chemicals. Toxicology in vitro : an international journal 
published in association with BIBRA 27, 1320-1346. 
 
[OECD] Organisation for Economic Co-operation and Development. 1992a.Test No. 203: 
Fish, Acute Toxicity Test. http://www.oecd-ilibrary.org/environment/test-no-203-fish-acute-
toxicity-test_9789264069961-en 
 
[OECD] Organisation for Economic Co-operation and Development. 1992b. Test No. 210: 
Fish, Early-Life Stage Toxicity Test. http://www.oecd-ilibrary.org/environment/test-no-210-
fish-early-life-stage-toxicity-test_9789264203785-en 
 
[OECD] Organisation for Economic Co-operation and Development. 1998. Test No. 211: 
Daphnia magna Reproduction Test. http://www.oecd-ilibrary.org/environment/test-no-211-
daphnia-magna-reproduction-test_9789264185203-en 
 
[OECD] Organisation for Economic Co-operation and Development. 2010a. Test No. 223: 
Avian Acute Oral Toxicity Test. http://www.oecd-ilibrary.org/environment/test-no-223-
avian-acute-oral-toxicity-test_9789264090897-en 
 
 19 
 
[OECD] Organisation for Economic Co-operation and Development. 2010b. Test No. 233: 
Sediment-Water Chironomid Life-Cycle Toxicity Test Using Spiked Water or Spiked 
Sediment. http://www.oecd-ilibrary.org/environment/test-no-233-sediment-water-
chironomid-life-cycle-toxicity-test-using-spiked-water-or-spiked-sediment_9789264090910-
en 
 
[OECD] Organisation for Economic Co-operation and Development. 2010c. Series on 
Testing and Assessment No. 126: Short guidance on the threshold approach for acute fish 
toxicity. 
http://www.oecd.org/officialdocuments/displaydocument/?cote=env/jm/mono(2010)17&docl
anguage=en 
 
[OECD] Organisation for Economic Co-operation and Development. 2012. Conceptual 
Framework for Testing and Assessment of Endocrine Disrupters. 
http://www.oecd.org/env/ehs/testing/oecdworkrelatedtoendocrinedisrupters.htm#CONCEPT
UAL 
 
[OECD] Organisation for Economic Co-operation and Development. 2013. Test No. 236: 
Fish Embryo Acute Toxicity (FET) Test. http://www.oecd-ilibrary.org/environment/test-no-
236-fish-embryo-acute-toxicity-fet-test_9789264203709-en 
 
Oris, J.T., Belanger, S.E. and Bailer, A.J. 2012. Baseline characteristics and statistical 
implications for the OECD 210 fish early-life stage chronic toxicity test. Environmental 
toxicology and chemistry / SETAC 31, 370-376. 
 
Piersma, A.H., Rorije, E., Beekhuijzen, M.E., Cooper, R., Dix, D.J., Heinrich-Hirsch, B., 
Martin, M.T., Mendez, E., Muller, A., Paparella, M., Ramsingh, D., Reaves, E., Ridgway, P., 
Schenk, E., Stachiw, L., Ulbrich, B. and Hakkert, B.C. 2011. Combined retrospective 
analysis of 498 rat multi-generation reproductive toxicity studies: on the impact of parameters 
related to F1 mating and F2 offspring. Reprod Toxicol 31, 392-401. 
 
Tanneberger, K., Knobel, M., Busser, F.J., Sinnige, T.L., Hermens, J.L. and Schirmer, K. 
2013. Predicting fish acute toxicity using a fish gill cell line-based toxicity assay. 
Environmental science & technology 47, 1110-1119. 
 
 20 
 
[US] Senate and House of Representatives of the United States of America. 2002. Federal 
Water Pollution Control Act (33 U.S.C. 1251 et seq.). 
 
[US] Senate and House of Representatives of the United States of America. 2008. Federal 
Insecticide, Fungicide, and Rodenticide Act (FIFRA). 
 
[US EPA] United States Environmental Protection Agency. 2011. Endocrine Disruptor 
Screening Program for the 21st Century: (EDSP21 Work Plan) The Incorporation of In Silico 
Models and In Vitro High Throughput Assays in the Endocrine Disruptor Screening Program 
(EDSP) for Prioritization and Screening. Washington, USA: US EPA. 
http://www.epa.gov/endo/pubs/edsp21_work_plan_summary%20_overview_final.pdf. Last 
accessed 11 March 2015. 
 
Villeneuve, D., Volz, D.C., Embry, M.R., Ankley, G.T., Belanger, S.E., Leonard, M., 
Schirmer, K., Tanguay, R., Truong, L. and Wehmas, L. 2014. Investigating alternatives to the 
fish early-life stage test: a strategy for discovering and annotating adverse outcome pathways 
for early fish development. Environmental toxicology and chemistry / SETAC 33, 158-169. 
 
Wheeler, J.R., Panter, G.H., Weltje, L. and Thorpe, K.L. 2013. Test concentration setting for 
fish in vivo endocrine screening assays. Chemosphere 92, 1067-1076. 
 
 
 
  
 21 
 
Box 1. Definition of the 3Rs. 
  
REPLACEMENT 
Methods which avoid or replace the 
use of animals 
 
REDUCTION 
Methods which minimise the number 
of animals used per experiment 
 
REFINEMENT 
Methods which minimise suffering 
and improve animal welfare 
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